ClinicalTrials.gov
public full text
Public Domain
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
Irritable bowel syndrome is characterized by the presence of chronic, recurrent abdominal pain, alterations in bowel habits, and abdominal distension. The medical diagnosis is made using the Rome IV criteria. There are three IBS phenotypes: diarrhea-predominant, constipation-predominant, and mixed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome#1161580
- Development and internal validation of a machine learning-based disease burden index for irritable bowel syndrome: a multicentre cross-sectional study.#479372
- Development and internal validation of a machine learning-based disease burden index for irritable bowel syndrome: a multicentre cross-sectional study.#477149
- The Effects of Rifaximin Therapy in Irritable Bowel Syndrome#1096268
- Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients#913811
Record · ID 837076
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive